Among them, the cyclin D-cyclin dependent kinase 4/6-inhibitor of CDK4-retinoblastoma (cyclinD-CDK4/6-INK4-RB) is an essential pathway for cancer cells to modulate G1 to S, which is important for many cancer types’ initiation, development, and survival (20, 21). Here, CDKN2A is linked to cancer.